Real-time enrollment status for this breast reconstruction clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 5:48 AM UTC
| NCT Number | NCT06575192 |
| Recruiting Status | Recruiting |
| Condition | Breast Reconstruction |
| Phase | PHASE3 |
| Target Enrollment | 264 participants |
| Active Locations | 23 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | August 6, 2026 (Aug 6, 2026) |
As of October 15, 2026: Clinical trial NCT06575192 is currently recruiting participants. This phase3 study for breast reconstruction is actively seeking new participants at 23 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06575192 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06575192 was last updated Aug 6, 2026 (August 6, 2026). HelloStudys verifies this status automatically.